MedPath

合肥利民制药有限公司

Ownership
-
Established
1998-10-22
Employees
-
Market Cap
-
Website
https://www.hflmzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

72

NMPA:72

Drug Approvals

Pranoprofen Eye Drops

Product Name
普拉洛芬滴眼液
Approval Number
国药准字H20249065
Approval Date
Oct 16, 2024
NMPA

Sodium Hyaluronate Eye Drops

Product Name
玻璃酸钠滴眼液
Approval Number
国药准字H20244674
Approval Date
Aug 20, 2024
NMPA

Ribavirin Nasal Drops

Product Name
利巴韦林滴鼻液
Approval Number
国药准字H20067225
Approval Date
Jun 19, 2024
NMPA

复方垂盆草胶囊

Approval Number
国药准字Z20090516
Approval Date
Dec 12, 2023
NMPA

舒冠胶囊

Approval Number
国药准字Z20090121
Approval Date
Dec 12, 2023
NMPA

Dieda Hongyao Pian

Product Name
跌打红药片
Approval Number
国药准字Z20055380
Approval Date
Sep 13, 2021
NMPA

Sucralfate Chewable Tablets

Product Name
硫糖铝咀嚼片
Approval Number
国药准字H34022662
Approval Date
Nov 23, 2020
NMPA

Paracetamol,Caffein,Atificial Cow-bezoar and Chlorphenamine Maleate Capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H34022126
Approval Date
Nov 16, 2020
NMPA

Hypromellose Eye Drops

Product Name
羟丙甲纤维素滴眼液
Approval Number
国药准字H20093895
Approval Date
Nov 4, 2020
NMPA

Foscarnet Soidum Eye Drops

Product Name
膦甲酸钠滴眼液
Approval Number
国药准字H20010644
Approval Date
Sep 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.